BUZZ-Henry Schein rises after BofA upgrades to 'buy'

Reuters

Jan 06, 2025

** Shares of healthcare products distributor Henry Schein HSIC.O rise ~4% to $71.94

** BofA Securities upgrades stock to "buy" from "underperform"; raises price objective to $84 from $69

** HSIC stands out as a "best-of-breed dental asset" with a proven ability to grow earnings at healthy rates, similar to its performance before COVID-19, brokerage says

** Company is well-positioned to gain share from both distributors and manufacturers due to its exposure to high-growth dental service organizations (DSO) customers and private label offerings - BofA Securities

** HSIC is positioned for long-term success with "best-in-class portfolio in dental", with above-market exposure to DSO customers - brokerage

** Six of 15 brokerages rate the stock "buy" or higher, 7 "hold" and 2 "sell"; median PT is $75 - data compiled by LSEG

** HSIC fell 8.6% in 2024

(Reporting by Kamal Choudhury in Bengaluru)

((Kamal.Choudhury@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2501258974"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2501258974\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2501258974?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-01-06 22:49","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2501258974","market":"us","top_or_hot":-1,"title":"BUZZ-Henry Schein rises after BofA upgrades to 'buy'","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BUZZ-Henry Schein rises after BofA upgrades to 'buy'</title></head><body><p>** Shares of healthcare products distributor Henry Schein <span>HSIC.O</span> rise ~4% to $71.94</p><p>** BofA Securities upgrades stock to \"buy\" from \"underperform\"; raises price objective to $84 from $69</p><p>** HSIC stands out as a \"best-of-breed dental asset\" with a proven ability to grow earnings at healthy rates, similar to its performance before COVID-19, brokerage says</p><p>** Company is well-positioned to gain share from both distributors and manufacturers due to its exposure to high-growth dental service organizations (DSO) customers and private label offerings - BofA Securities</p><p>** HSIC is positioned for long-term success with \"best-in-class portfolio in dental\", with above-market exposure to DSO customers - brokerage</p><p>** Six of 15 brokerages rate the stock \"buy\" or higher, 7 \"hold\" and 2 \"sell\"; median PT is $75 - data compiled by LSEG</p><p>** HSIC fell 8.6% in 2024</p><p> (Reporting by Kamal Choudhury in Bengaluru)</p><p> ((Kamal.Choudhury@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BUZZ-Henry Schein rises after BofA upgrades to 'buy'</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBUZZ-Henry Schein rises after BofA upgrades to 'buy'\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-01-06 22:49</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BUZZ-Henry Schein rises after BofA upgrades to 'buy'</title></head><body><p>** Shares of healthcare products distributor Henry Schein <span>HSIC.O</span> rise ~4% to $71.94</p><p>** BofA Securities upgrades stock to \"buy\" from \"underperform\"; raises price objective to $84 from $69</p><p>** HSIC stands out as a \"best-of-breed dental asset\" with a proven ability to grow earnings at healthy rates, similar to its performance before COVID-19, brokerage says</p><p>** Company is well-positioned to gain share from both distributors and manufacturers due to its exposure to high-growth dental service organizations (DSO) customers and private label offerings - BofA Securities</p><p>** HSIC is positioned for long-term success with \"best-in-class portfolio in dental\", with above-market exposure to DSO customers - brokerage</p><p>** Six of 15 brokerages rate the stock \"buy\" or higher, 7 \"hold\" and 2 \"sell\"; median PT is $75 - data compiled by LSEG</p><p>** HSIC fell 8.6% in 2024</p><p> (Reporting by Kamal Choudhury in Bengaluru)</p><p> ((Kamal.Choudhury@thomsonreuters.com;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BAC","symbol_name":"美国银行","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250106:nL4N3O210J:1","article_id":"2501258974","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2501258974","pubTimestamp":1736174957,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BUZZ-Henry Schein rises after BofA upgrades to 'buy'** Shares of healthcare products distributor Henry Schein HSIC.O rise ~4% to $71.94** BofA Securities upgrades stock to \"buy\" from \"underperform\"; raises price objective to $84 from $69** HSIC stands out as a \"best-of-breed dental asset\" with a proven ability to grow earnings at healthy rates, similar to its performance before COVID-19, brokerage says** Company is well-positioned to gain share from both distributors and manufacturers due to its exposure to high-growth dental service organizations  customers and private label offerings - BofA Securities** HSIC is positioned for long-term success with \"best-in-class portfolio in dental\", with above-market exposure to DSO customers - brokerage** Six of 15 brokerages rate the stock \"buy\" or higher, 7 \"hold\" and 2 \"sell\"; median PT is $75 - data compiled by LSEG** HSIC fell 8.6% in 2024  ","collect":0,"end_time":0,"defaultTopTitle":"","property":["rate"],"viewcount":null,"language":"en","relate_stocks":{"BAC":"美国银行","HSIC":"汉瑞祥"},"translate_title":"美国银行上调评级至“买入”后，BUZZ-Henry Schein股价上涨","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"BAC":0.9,"HSIC":0.9},"content_text":"BUZZ-Henry Schein rises after BofA upgrades to 'buy'** Shares of healthcare products distributor Henry Schein HSIC.O rise ~4% to $71.94** BofA Securities upgrades stock to \"buy\" from \"underperform\"; raises price objective to $84 from $69** HSIC stands out as a \"best-of-breed dental asset\" with a proven ability to grow earnings at healthy rates, similar to its performance before COVID-19, brokerage says** Company is well-positioned to gain share from both distributors and manufacturers due to its exposure to high-growth dental service organizations (DSO) customers and private label offerings - BofA Securities** HSIC is positioned for long-term success with \"best-in-class portfolio in dental\", with above-market exposure to DSO customers - brokerage** Six of 15 brokerages rate the stock \"buy\" or higher, 7 \"hold\" and 2 \"sell\"; median PT is $75 - data compiled by LSEG** HSIC fell 8.6% in 2024 (Reporting by Kamal Choudhury in Bengaluru) ((Kamal.Choudhury@thomsonreuters.com;))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}